Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex tests unmanned cargo transportation on the highway Don

10/17/24 YDEX

UTair passenger traffic on airplanes increased by 5.1% in January-September

10/17/24 UTAR

Sberbank bought online schools Netology and Foxford

10/17/24 SBER

Ozone Pharmaceuticals IPO went through the top line

10/17/24 OZPH

T-Bank opened a library of AI-based tools

10/17/24 TCSG

Finuservices launched trading of exchange-traded instruments

10/17/24 MOEX

Ozon launched its operations in Uzbekistan

10/16/24 OZON

SFI reported for 9 months of 2024 by RAS

10/16/24 SFIN

OGK-2's power generation in 9 months increased by 10%

10/16/24 OGKB

PIK sold two sites in Moscow

10/16/24 PIKK